SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mitsuha Hayashi, Yoshinori Umezawa, Osamu Fukuchi, Toshihiro Ito, Hidehisa Saeki, Hidemi Nakagawa, Efficacy and safety of ustekinumab treatment in elderly patients with psoriasis, The Journal of Dermatology, 2014, 41, 11
  2. 2
    Alexander Gin, Con Dolianitis, Multidrug resistant miliary tuberculosis during infliximab therapy despite tuberculosis screening, Australasian Journal of Dermatology, 2014, 55, 2
  3. 3
    Christine Deffert, Julien Cachat, Karl-Heinz Krause, Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections, Cellular Microbiology, 2014, 16, 8
  4. 4
    A.I. Sánchez-Moya, I. García-Doval, G. Carretero, J. Sánchez-Carazo, C. Ferrandiz, E. Herrera Ceballos, M. Alsina, M. Ferrán, J.-L. López-Estebaranz, F. Gómez-García, P. De la Cueva Dobao, J.-M. Carrascosa, F. Vanaclocha, I. Belinchón, F. Peral, E. Dauden, Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate–severe psoriasis in Spain. BIOBADADERM registry, Journal of the European Academy of Dermatology and Venereology, 2013, 27, 11
  5. 5
    Caius Solovan, Elena Chiticariu, Psoriasis, Anti-Tumor Necrosis Factor Therapy, and Tuberculosis: Report of Three Challenging Cases and Literature Review, Infectious Diseases and Therapy, 2013, 2, 1, 59

    CrossRef

  6. You have free access to this content6
    ID O’Neill, C Scully, Biologics in oral medicine: principles of use and practical considerations, Oral Diseases, 2012, 18, 6
  7. 7
    P. De Mozzi, G.A. Johnston, A.B. Alexandroff, Psoriasis: an evidence-based update. Report of the 9th Evidenced Based Update Meeting, 12 May 2011, Loughborough, U.K., British Journal of Dermatology, 2012, 166, 2
  8. 8
    Giampiero Girolomoni, Gianfranco Altomare, Fabio Ayala, Enzo Berardesca, Piergiacomo Calzavara-Pinton, Sergio Chimenti, Andrea Peserico, Antonio Puglisi Guerra, Gino Antonio Vena, Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis, Immunopharmacology and Immunotoxicology, 2012, 34, 4, 548

    CrossRef

  9. You have free access to this content9
    T.-F. Tsai, V. Ho, M. Song, P. Szapary, T. Kato, Y. Wasfi, S. Li, Y.K. Shen, C. Leonardi, The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection, British Journal of Dermatology, 2012, 167, 5
  10. 10
    Y. Z. Chiang, K. Panting, B. Dever, R. A. G. Parslew, Clinical applicability of T-cell interferon-α release assay for tumour necrosis factor-α inhibitor therapy in severe psoriasis, Clinical and Experimental Dermatology, 2011, 36, 1
  11. 11
    H-Y. Chiu, P-R. Hsueh, T-F. Tsai, Clinical experience of QuantiFERON®-TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan, British Journal of Dermatology, 2011, 164, 3
  12. 12
    A.I. Sánchez-Moya, E. Daudén, Diagnosing latent tuberculosis infection in patients with psoriasis under antitumour necrosis factor-α treatment: every new solution breeds new doubts, British Journal of Dermatology, 2011, 164, 1
  13. 13
    AI Sánchez-Moya, E Dauden, Incidence of tuberculosis infection in psoriatic patients on anti-TNF therapy: report of a case series with 144 patients, Journal of the European Academy of Dermatology and Venereology, 2011, 25, 6
  14. 14
    T.O. Bleiker, R.E.M. Hughes, British Journal of Dermatology: a fresh complexion, British Journal of Dermatology, 2010, 162, 1
  15. 15
    Rosa María Fernández Torres, Sabela Paradela De La Morena, Eduardo Fonseca Capdevila, Cribado de la infección tuberculosa en pacientes tratados con fármacos biológicos, Piel, 2010, 25, 1, 15

    CrossRef

  16. 16
    S. J. Fraser, A. T. Hill, D. A. McKay, W. A. Reid, M. E. Mathers, G. MacDougall, O. M. V. Schofield, Cutaneous tuberculosis revealed by infliximab therapy for presumed sarcoidosis, Clinical and Experimental Dermatology, 2010, 35, 4
  17. 17
    B. González-Sixto, M.Á. Rodríguez-Prieto, Etanercept e infección latente tuberculosa, Actas Dermo-Sifiliográficas, 2010, 101, 62

    CrossRef

  18. You have free access to this content18
    Maria Moscandrew, Uma Mahadevan, Sunanda Kane, General health maintenance in IBD, Inflammatory Bowel Diseases, 2009, 15, 9
  19. 19
    Mandeep S. Jassal, William R. Bishai, The Risk of Infections With Tumor Necrosis Factor-α Inhibitors, JCR: Journal of Clinical Rheumatology, 2009, 15, 8, 419

    CrossRef